1) Contrast-enhanced CT
增强CT
1.
Comparison of contrast-enhanced ultrasonography and contrast-enhanced CT in small hepatic lesions
肝脏小占位病变超声造影与增强CT比较
2.
The dynamic contrast enhancement and echogenicity of contrast-enhanced ultrasound (CEUS) were recorded and compared with the results of contrast-enhanced CT respectively.
目的：应用新型造影剂SonoVue结合反向脉冲谐波显像(pulse-inversion harmonic imaging，PIH)技术显示肝良恶性肿瘤超声造影的动态灌注过程及回声变化规律，并与增强CT结果进行对比，比较两种技术显示肝肿瘤不同的血流动力学表现，分析肝肿瘤血流灌注特点及血供特征，评价其对肝良恶性肿瘤的诊断价值及在肝癌手术方案选择和预后判断等方面的临床应用价值。
3) CT enhancement
CT增强
1.
Application study between integrated catheter and scalp needle in CT Enhancement scan;
套管针与头皮针在CT增强扫描中的应用研究
2.
Correlative study between CT enhancement extent and pathological types in peripheral pulmonary carcinoma;
周围型肺癌CT增强幅度与其病理类型的相关性分析
3.
Summarizes a set of useful nursing methods after nursing 300 cases of patients scanned by CT enhancement so as to ensure that the scanning is completed smoothly.
通过对300例CT增强扫描的病人护理,总结出一套行之有效的护理方法,从而保证扫描的顺利完成。
4) Contrast-enhanced CT/MR
增强CT/MR
5) noncontrast CT
非增强CT
1.
Identification of the penumbra and infarct core on noncontrast CT scan;
早期脑缺血非增强CT检查在预测缺血核和半暗带中的作用
6) Contranst enhanced maps
CT增强图
补充资料：肝延迟大剂量增强CT
肝延迟大剂量增强CT
影像学术语。一次大剂量注射对比剂后4～6小时重复扫描的肝脏CT检查方法。碘对比剂进入肝脏的血管系统(含再循环)后，有1%～2%滞留在肝细胞内。注射60g碘4～6小时后，滞留在肝细胞内的碘对比剂在平扫图像上可使肝密度增加约20HU。极少的循环碘也可滞留于血池中并释放进入肿瘤，有助于最大程度地显示病灶。这种技术有助于评价动态增强CT或动脉性门脉造影CT显示的可疑恶性病灶，使发现病灶的敏感性提高，但不能鉴别小的病灶和中央性血管。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条